Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
4(29%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
5
36%
Ph phase_2
2
14%
Ph phase_4
5
36%

Phase Distribution

0

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
2(16.7%)
Phase 4Post-market surveillance
5(41.7%)
N/ANon-phased studies
5(41.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

14

all time

Status Distribution
Active(4)
Completed(10)

Detailed Status

Completed10
Recruiting3
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (16.7%)
Phase 45 (41.7%)
N/A5 (41.7%)

Trials by Status

active_not_recruiting17%
recruiting321%
completed1071%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT07358416

Complications and Antiplatelet and Anticoagulant Therapy in Vascular Surgery.

Active Not Recruiting
NCT06238115Phase 2

Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair

Completed
NCT06638151Phase 2

Clopidogrel Plus Aspirin in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPrime)

Recruiting
NCT05353140Not Applicable

LAAO Versus NOAC in Patients with AF and PCI

Recruiting
NCT05638867Phase 4

NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI

Recruiting
NCT03823274

Multi-center, Prospective, Cohort Study to Evaluate the Relationship of Stroke Recurrence and Anti-platelet Resistance in Ischemic Stroke Patients

Completed
NCT03198741Phase 4

Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent Implantation

Completed
NCT02247128Phase 4

Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation

Completed
NCT00262275Not Applicable

Optimum Platelet Inhibition After Coronary Bypass Surgery

Completed
NCT00882388Phase 4

The Effect of Celecoxib on the Antiplatelet Effect of Aspirin and Clopidogrel in Normal Volunteers

Completed
NCT01094457Phase 4

Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent Implantation

Completed
NCT00418860Not Applicable

The Optimal Duration of Dual Antiplatelet Therapy After Implantation of Endeavor Stent

Completed
NCT00620646Not Applicable

The Comparison of Effects Between Increased Dose of Clopidogrel and Addition of Cilostazol

Completed
NCT00662467Not Applicable

Warfarin After Anterior ST-Elevation Myocardial Infarction

Completed

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14